BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 15, 2011
View Archived Issues
First-in-human data suggest safety of LY-2090314 in patients with advanced solid tumors
Read More
KIST researchers prepare new protein kinase inhibitors
Read More
Novel anticancer macrocyclic lactones presented
Read More
New antagonists of dopamine D2 receptor and serotonin 5-HT7 receptor claimed
Read More
Merck Frosst presents new renin inhibitors
Read More
Allergy Therapeutics receives complete report from PEI on MAA for Pollinex Quattro/Complete
Read More
Secukinumab reduces symptoms of active rheumatoid arthritis in clinical settings
Read More
MLN-4924 has effects in acute myeloid leukemia and high-grade myelodysplastic syndrome
Read More
Pasireotide reduces elevated urinary free cortisol in patients with Cushing's disease
Read More
Novel serum stroke biomarkers investigated
Read More
Albany Molecular Research and Merck & Co. disclose new agents for HIV
Read More
Preliminary phase IIa data announced on EPI-A0001 in Friedreich's ataxia
Read More
FDA approves Abbott's infant-specific Creon dose
Read More
New company BliNK Therapeutics to develop monoclonal antibodies
Read More
Vertex and Alios BioPharma enter into agreement for nucleotide drug candidates
Read More
Phase I trial of therapeutic anticancer vaccine OCV-105 begins in Japan
Read More
FDA grants orphan drug status to Neo-Urinary Conduit
Read More
LY-2624803 improves aspects of chronic insomnia in phase II trial
Read More
Adolor enters agreement to reacquire full rights to alvimopan hydrate from GSK
Read More
Scripps Research Institute receives NIH grant for addiction research
Read More
FDA extends PDUFA target date for review of Exparel NDA
Read More
Lundbeck completes final trial of phase III nalmefene program in alcohol dependence
Read More
JDFR and Selecta Biosciences collaborate on vaccines for type 1 diabetes
Read More
Bayer HealthCare submits IND application for BAY-94-9343
Read More
CytRx reports encouraging preliminary data from phase II ENABLE trial of bafetinib in B-CLL
Read More
Antisense Therapeutics clear to begin phase I ATL-1103 trial in Australia
Read More
